Abiona Therapeutics Inc. filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission on September 15, 2026. The filing was submitted to update the public on the company's participation in an upcoming investment conference.
The report indicates that the company intends to use an updated investor presentation at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation is scheduled to be delivered or utilized in part on September 15, 2026.
Abiona Therapeutics Inc. is incorporated in Delaware and has its principal executive offices located at 6555 Carnegie Ave, 4th Floor, Cleveland, OH 44103. The company's common stock trades on The Nasdaq Capital Market under the ticker symbol ABEO.
The filing includes an exhibit containing the investor presentation dated September 15, 2026. The document is incorporated by reference into Item 7.01 of the report.
The report was signed by Joseph Vazzano, the Chief Financial Officer of the company, on the same date as the filing.
